Abstract
Data regarding tellurium (Te) toxicity are scarce but metabolic studies in bacteria highlight a major role of reactive oxygen species (ROS). Concentration- and time-dependent cell death has been reported in cancer cells exposed to inorganic tellurite. However, the potential in vitro effect that tellurite could generates in non-transformed human cells is still unknown. Therefore, we have studied the toxicity of inorganic tellurite (K2TeO3) in both freshly isolated peripheral blood leukocytes and in human chronic myeloid leukemia cells (K562 cells). Interestingly, we observed higher increases of ROS in leukocytes after treatment with tellurite, as compared to K562 cells. Given the high reactivity of tellurite with glutathione (GSH), a mechanism that leads to ROS formation (and mainly superoxide anion), we postulate that such a difference between cancer and normal cells is likely due to the higher GSH contents found in leukocytes versus leukemia cells. Taken together, our data point out the major differences that can be observed between cancer and corresponding normal cells in studies looking for in vitro toxicity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
